comparemela.com

Latest Breaking News On - Reverse phase protein array technology - Page 1 : comparemela.com

Theralink® Technologies Appoints Seasoned Commercial Leader, Faith Zaslavsky, as President & Chief Operating Officer for its Precision Oncology Company

Theralink® Technologies Appoints Seasoned Commercial Leader, Faith Zaslavsky, as President & Chief Operating Officer for its Precision Oncology Company - read this article along with other careers information, tips and advice on BioSpace

United statesMick ruxinWashington state universityTheralink technologies incCompany theralinkInterest in reverse phase protein array technologyExchange commissionNational salesCompany codesBusiness administrationSeasoned genomics commercial leaderSpecial interestReverse phase protein array technologyLead theralinkFaith zaslavskyChief operating officer

Theralink® Technologies Appoints Seasoned Commercial Leader, Faith Zaslavsky, as President & Chief Operating Officer for its Precision Oncology Company

/PRNewswire/ Theralink Technologies (OTC: THER) ("Theralink" or the "Company"), the only US precision oncology company with commercial RPPA technology that.

United statesMick ruxinInterest in reverse phase protein array technologyWashington state universityTheralink technologies incNational salesBusiness administrationCompany theralinkSeasoned genomics commercial leaderSpecial interestReverse phase protein array technologyLead theralinkFaith zaslavskyChief operating officerMedical servicesMedical affairs

Theralink® Technologies Appoints Dr Mattia Cremona as its Director of its Biopharma Laboratory

/PRNewswire/ Theralink Technologies, Inc. (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel phosphoprotein-based assay.

United statesUnited kingdomMick ruxinMattia cremonaBiopharma laboratoryTheralink technologies incGeorge mason universitySeasoned cancer researchPhase protein array technologyRoyal college of surgeonsSeasoned cancer research fellowReverse phase protein array technologyTheralink technologiesResearch fellowRoyal collegeReverse phase protein array

Theralink® Acquires Two New Milestone Patents Relating to Methods for Treating Breast Cancer

/PRNewswire/ Theralink Technologies, Inc. (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel phosphoprotein-based assay.

United statesEmanuel petricoinMick ruxinGeorge mason universityTheralink technologies incPhase protein array technologyPredictive biomarker patentsBreast cancerTheralink technologiesScience advisory boardReverse phase protein array technologyTheralink assayPatent detailsTreating breast cancerReverse phase protein array

vimarsana © 2020. All Rights Reserved.